1.Intraductal Carcinoma of the Prostate Gland: Recent Advances.
Yonsei Medical Journal 2016;57(5):1054-1062
Intraductal carcinoma of the prostate (IDC-P) is characterized by prostatic carcinoma involving ducts and/or acini. The presence of IDC-P is usually associated with a high-grade Gleason score, large tumor volume, and adverse prognostic parameters, including extraprostatic extension and seminal vesicle invasion. When present, IDC-P is associated with worse outcomes, regardless of treatment status. IDC-P is included in a broader diagnostic category of atypical cribriform lesions of the prostate gland. This category of lesions also includes high-grade prostatic intraepithelial neoplasia (HGPIN), urothelial carcinoma involving prostatic ducts or acini, and prostatic ductal adenocarcinoma, amongst other intraductal proliferations. Differentiating between these entities is important as they have differing therapeutic and prognostic implications for patients, although differential diagnosis thereof is not always straightforward. The present review discusses IDC-P in regards to its morphological characteristics, molecular features, and clinical outcomes. Given the current state of knowledge, the presence of IDC-P should be evaluated and documented correctly in both radical prostatectomy and needle biopsy specimens, and the clinical implications thereof should be taken into consideration during treatment and follow up.
Carcinoma, Acinar Cell/chemistry/*diagnosis/pathology
;
Carcinoma, Ductal/chemistry/*diagnosis/pathology
;
Carcinoma, Transitional Cell/chemistry/*diagnosis/pathology
;
Diagnosis, Differential
;
Humans
;
Male
;
Neoplasm Grading
;
Prostatic Intraepithelial Neoplasia/chemistry/*diagnosis/pathology
;
Prostatic Neoplasms/chemically induced/*diagnosis/*pathology
;
Tumor Burden
2.Role of cytokeratin expression in differential diagnosis of intraductal proliferative lesions of breast.
Jing-li ZHANG ; Hong-ying ZHANG ; Bing WEI ; Zhi-qiang LANG ; Hong BU
Chinese Journal of Pathology 2004;33(4):316-319
OBJECTIVETo evaluate the expression of cytokeratins in intraductal proliferative lesions of breast, including usual ductal hyperplasia (UDH), atypical ductal hyperplasia (ADH), ductal carcinoma-in-situ (DCIS) and its role in differential diagnosis.
METHODSNinety two cases of paraffin-embedded lesional breast tissue, 30 cases of frozen samples, cell cultures of hyperplastic ductal cells and 2 invasive ductal carcinoma cell lines (T47D and MCF-7) were used for this study. Immunohistochemistry was performed using EnVision method for 34betaE12, CK8 and CK14.
RESULTSThe percentage of 34betaE12-positivity in paraffin-embedded samples of UDH, ADH, DCIS and invasive ductal carcinoma (IDC) was found to be 95.2%, 33.3%, 19.2% and 12.5% respectively. In frozen tissues, all UDH cases and 55% of IDC cases expressed 34betaE12. The primary UDH cell cultures and T47D cell line were also 34betaE12-positive, whereas MCF7 cell line showed negative staining. The expression rate of CK8 and CK14 in UDH was also different from that in ADH and DCIS.
CONCLUSIONS34betaE12 can be useful in differential diagnosis of intraductal proliferative lesions of the breast. However application of this cytokeratin stain in intraoperative frozen sections is relatively limited. The expression patterns of CK8 and CK14 are also helpful in the differential diagnosis of similar lesions.
Breast ; chemistry ; pathology ; Breast Neoplasms ; chemistry ; diagnosis ; pathology ; Carcinoma, Ductal, Breast ; chemistry ; diagnosis ; pathology ; Carcinoma, Intraductal, Noninfiltrating ; chemistry ; diagnosis ; Cell Line, Tumor ; Diagnosis, Differential ; Female ; Humans ; Hyperplasia ; Keratins ; analysis ; Precancerous Conditions ; chemistry ; pathology
3.Diagnosis of invasive micropapillary carcinoma.
Chinese Journal of Pathology 2004;33(4):305-307
Breast Neoplasms
;
chemistry
;
diagnosis
;
pathology
;
Carcinoma, Ductal, Breast
;
chemistry
;
diagnosis
;
pathology
;
Carcinoma, Papillary
;
chemistry
;
diagnosis
;
pathology
;
Diagnosis, Differential
;
Female
;
Humans
;
Lymphatic Metastasis
;
Neoplasm Invasiveness
;
Prognosis
;
Receptor, ErbB-2
;
analysis
;
Receptors, Estrogen
;
analysis
4.FTIR spectroscopic characterization of freshly removed breast cancer tissues.
Su ZHOU ; Zhi XU ; Xiao-Feng LING ; Qing-Bo LI ; Yi-Zhuang XU ; Li ZHANG ; Hong-Mei ZHAO ; Li-Xin WANG ; Kuan-Yong HOU ; Xiao-Si ZHOU ; Jin-Guang WU
Chinese Journal of Oncology 2006;28(7):512-514
OBJECTIVETo identify the FTIR spectroscopic characterization of breast cancer and explore the possibility of application of FTIR in differentiation of malignant and benign breast lesions.
METHODSFTIR spectra of surgically removed fresh breast tissues were measured by spectrometer equipped with mid-infrared fiber optics and an ATR probe. Peaks in the spectra were measured and relative intensity ratios were calculated and analyzed if there are significant differences between the spectra of malignant and benign breast lesions.
RESULTSThere were significant differences (P < 0.05) between the spectra of malignant breast cancers and benign breast tissues in the relative intensity ratios of different peaks (I1640/ I1550 and I1160/I1120 for protein structures; I1640/I1460 and I1550/I1460 for relative content of protein and lipid; I1460/I1400 for lipid structures; I1310/I1240 for nucleic acid).
CONCLUSIONFTIR spectroscopy could be a useful tool in clinical diagnosis of breast cancer.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Breast ; chemistry ; pathology ; Breast Neoplasms ; diagnosis ; metabolism ; Carcinoma, Ductal, Breast ; diagnosis ; metabolism ; Female ; Fibroadenoma ; diagnosis ; metabolism ; Humans ; Lipids ; analysis ; Middle Aged ; Neoplasm Proteins ; analysis ; Reproducibility of Results ; Sensitivity and Specificity ; Spectroscopy, Fourier Transform Infrared ; methods